23690868

Benrick A

2013

Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic ovary syndrome.

23696936

Dong X

2013

Does progesterone-induced endometrial withdrawal bleed before ovulation induction have negative effects on IUI outcomes in patients with polycystic ovary syndrome?

23697264

Skrgati? L

2013

Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.

23700321

Ormazabal P

2013

Testosterone modulates the expression of molecules linked to insulin action and glucose uptake in endometrial cells.

23700477

Chakraborty P

2013

Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance.

23700857

Boztosun A

2013

Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.

23700863

Kisielewski R

2013

Inflammation and ovarian cancer--current views.

23701728

Padmanabhan V

2013

Animal models of the polycystic ovary syndrome phenotype.

23705014

Shen HR

2013

Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome.

23705521

Kamboj MK

2013

Updates in pediatric endocrinology.

23706336

Hoang YD

2013

Paracrine regulation of theca androgen production by granulosa cells in the ovary.

23707553

Perales-Puchalt A

2013

Ovulation induction in women with polycystic ovary syndrome.

23708322

Colazingari S

2013

The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.

23709086

Orisaka M

2013

Dysregulation of ovarian follicular development in female rat: LH decreases FSH sensitivity during preantral-early antral transition.

23717068

Jung JH

2011

Therapeutic effect of korean red ginseng extract on infertility caused by polycystic ovaries.

23721073

J?rgensen JS

2013

First Nordic Conference on Obesity in Gynecology and Obstetrics (NOCOGO).

23721173

Baranova A

2013

Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS).

23723134

Zhao H

2013

Genetic association studies in female reproduction: from candidate-gene approaches to genome-wide mapping.

23724519

Jidong W

2013

Lentivirus vectors mediated eGFP transfected into rat ovary in vivo.

23724531

Unluer AN

2013

Comparison of HbA1c levels in obese and non-obese polycystic ovarian patients.

23726135

Auble B

2013

Differences in the management of adolescents with polycystic ovary syndrome across pediatric specialties.

23726743

Sahing?z M

2013

Axis I and Axis II diagnoses in women with PCOS.

23727147

Schenck-Gustafsson K

2013

Cardiology for gynecologists--a minireview.

23727374

Laroche E

2013

[Diagnosis and management of amenorrhea in adolescent girls].

23727939

Moran LJ

2013

Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.

23728677

Zhuang J

2013

Antidepressants for polycystic ovary syndrome.

23731880

Pedersen SD

2013

Metabolic complications of obesity.

23732149

Sudano I

2013

Potential new indications and future studies.

23734045

Labruijere S

2013

Analysis of the vascular responses in a murine model of polycystic ovary syndrome.

23739218

Veltman-Verhulst SM

2013

Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.

23739223

Teede HJ

2013

Screening for glycaemic abnormalities in PCOS: an ongoing controversy.

23741965

Guvendag Guven ES

2013

The effect of cabergoline on folicular microenviroment profile in patients with high risk of OHSS.

23744432

Masszi G

2013

Effects of vitamin D3 derivative--calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model.

23745331

Marciniak A

2013

[Chronic inflammation and metabolic syndrome in comparison with other signs belonging to the image of polycystic ovary syndrome].

23746214

Dawson AJ

2014

A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease.

23746545

T?rk M

2013

Multisystem disorder and limb girdle muscular dystrophy caused by LMNA p.R28W mutation.

23746632

Liu HW

2013

Effects of apolipoprotein E genotypes on metabolic profile and oxidative stress in southwest Chinese women with polycystic ovary syndrome.

23748472

Shaikh N

2013

Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome.

23750031

Stubbs SA

2013

Role of Insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries.

23756098

Christensen SB

2013

Prevalence of polycystic ovary syndrome in adolescents.

23756702

Lerchbaum E

2013

Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.

23756703

Palomba S

2013

Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome.

23758202

Hayashida SA

2014

Evaluation of macroprolactinemia in 259 women under investigation for polycystic ovary syndrome.

23762054

Gregoraszczuk EL

2013

Endocrine-Disrupting Chemicals: Some Actions of POPs on Female Reproduction.

23762116

Li QQ

2013

Acupuncture effect and central autonomic regulation.

23763006

Wiser A

2013

Effect of high LH/FSH ratio on women with polycystic ovary syndrome undergoing in vitro maturation treatment.

23763822

Stener-Victorin E

2013

Acupuncture and physical exercise for affective symptoms and health-related quality of life in polycystic ovary syndrome: secondary analysis from a randomized controlled trial.

23764390

Croze ML

2013

Potential role and therapeutic interests of myo-inositol in metabolic diseases.

23766891

Padmanabhan V

2012

Developmental programming: Impact of prenatal testosterone treatment and postnatal obesity on ovarian follicular dynamics.

23768619

Zhang N

2013

Prediction of IVF/ICSI outcome based on the follicular output rate.

23768911

Teede H

2013

Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.

23769016

De Leo V

2013

Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.

23769547

Qiao J

2013

Pay more attention to ethnic differences in polycystic ovary syndrome phenotypic expression.

23769971

Li L

2013

Relationship between leptin receptor and polycystic ovary syndrome.

23770686

Eren E

2013

Does hyperandrogenism affect the otoacoustic emissions and medial olivocochlear reflex in female adults?

23771201

Moran LJ

2013

The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.

23772274

Gomez-Meade CA

2013

Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome.

23772775

Fan W

2013

Association between the (TAAAA)n SHBG polymorphism and PCOS: a systematic review and meta-analysis.

23772776

Kedem A

2013

Anti-M?llerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments.

23775353

Iliodromiti S

2013

Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data.

23776851

Kamalanathan S

2013

Pregnancy in polycystic ovary syndrome.

23776867

Ramanand SJ

2013

Clinical characteristics of polycystic ovary syndrome in Indian women.

23777024

Iyer SR

2012

Sleep and type 2 diabetes mellitus- clinical implications.

23781168

Peluso JJ

2013

Progesterone receptor membrane component 1 and its role in ovarian follicle growth.

23781594

Caserta D

2013

Endometrial adenocarcinoma in a young woman.

23782000

Sadat Hosseini M

2013

The lack of association between idiopathic hirsutism and metabolic disturbances: Iranian PCOS Prevalence Study.

23782540

Decanter C

2013

First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?

23786328

Banerjee P

2013

Diverse roles of metformin during peri-implantation development: revisiting novel molecular mechanisms underlying clinical implications.

23794114

Lakkakula BV

2013

Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review.

23795968

McEwan IJ

2013

Androgen receptor modulators: a marriage of chemistry and biology.

23796010

Fenichel P

2013

Bisphenol A: an endocrine and metabolic disruptor.

23796160

Sam AH

2013

Hepcidin levels in diabetes mellitus and polycystic ovary syndrome.

23798298

Booth FW

2012

Lack of exercise is a major cause of chronic diseases.

23800002

Qin JZ

2013

Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis.

23801024

Adamska A

2013

Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome.

23801097

Paoli A

2013

Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.

23803145

Zeng X

2013

Impact of obesity on endometrial blood flow in women without polycystic ovarian syndrome during intracytoplasmic sperm injection.

23803197

Geng X

2013

[Effect of basal serum luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio on outcomes of in vitro fertilization-embryo transfer in patients with polycystic ovarian syndrome].

23806449

Sahmay S

2013

Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.

23806848

Son WY

2013

Fertilization and embryo development with spermatozoa obtained from testicular sperm extraction into oocytes generated from human chorionic gonadotropin-primed in vitro maturation cycles.

23807979

Mumdzhiev H

2013

[Intrauterine hypotrophy and programming the health status. Late problems in newborns with intrauterine hypotrophy].

23808904

Hu YJ

2014

Letrozole stimulation in endometrial preparation for cryopreserved-thawed embryo transfer in women with polycystic ovarian syndrome: a pilot study.

23809623

Legro RS

2013

Introduction: back to the future: origins of polycystic ovary syndrome.

23809624

Abbott DH

2013

Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

23809625

Witchel SF

2013

The Kiss1 system and polycystic ovary syndrome: lessons from physiology and putative pathophysiologic implications.

23812344

Moran LJ

2013

Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.

23814096

Li R

2013

Prevalence of polycystic ovary syndrome in women in China: a large community-based study.

23816935

McManus SS

2013

Polycystic ovary syndrome: clinical presentation in normal-weight compared with overweight adolescents.

23818240

Philp LK

2013

SGTA: a new player in the molecular co-chaperone game.

23818329

Teede HJ

2013

Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women.

23820138

Shi Y

2013

White blood cell differential counts in patients with polycystic ovary syndrome: a pilot study on Chinese women.

23820423

Sunj M

2013

Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome?

23822891

Shafiee MN

2013

Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift?

23823020

Chatzigeorgiou A

2013

Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats.

23823925

Tsakova AD

2012

25(OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity.

23824412

Piltonen TT

2013

Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.

23824416

Riedl S

2013

Hypothesis: Persistently elevated hCG causes gestational ovarian overstimulation associated with prolonged postpartum hyperandrogenism in mothers of aromatase-deficient babies.

23825680

Gao H

2013

Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population.

23826984

Sprung VS

2014

Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition.

23830153

Graff SK

2013

Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.